Psoriasis

Frequency of monitoring depends on disease severity and the type of therapy that the patients are taking. In general, monitor patients with moderate to severe psoriasis at 3- to 6-month intervals. Clinicians need to ensure that treatment goals are met and continually monitor for drug safety.